Sign In
Learn bits
Health & Medicine
Pradeep Kumar

09/05/21 09:20 AM IST

Anti-COVID drug developed by DRDO

In news

An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO)

About the drug
  • The drug comes in powder form in a sachet and is taken orally by dissolving it in water.
  • It accumulates in the virus-infected cells and prevents virus growth by stopping viral synthesis and energy production.
  • Its selective accumulation in virally infected cells makes this drug unique.
  • Clinical trial results of the drug have shown that it helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.
  • A higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in COVID patients.
Source: PIB, The Hindu

More Related Current Affairs View All

15 Nov

Government issues guidelines to curb misleading ads by coaching centres

'The central Government issued new guidelines aimed at curbing misleading advertisements by coaching institutes, specifically prohibiting false promises such as "100 per cent selec

Read More

15 Nov

Janjatiya Gaurav Divas

'Every year on November 15th, Janjatiya Gaurav Divas is celebrated to honor the contributions of these communities, especially in India’s freedom struggle.' 5th November

Read More

15 Nov

Supreme Court’s order on mandatory accessibility standards

'A bench of the Supreme Court last week ordered the Union government to frame mandatory rules for ensuring the accessibility of public places and services to persons with disabilit

Read More

India’s First Ai-Driven Magazine Generator

Generate Your Custom Current Affairs Magazine using our AI in just 3 steps